Systemic HER3 ligand-mimicking nanobioparticles enter the brain and reduce intracranial tumour growth

By sjmartinez • February 22, 2025

Alonso-Valenteen F, Mikhael S, Wang H, Sims J, Taguiam M, Teh J, Sances S, Wong M, Miao T, Srinivas D, Gonzalez-Almeyda N, Cho RH, Sanchez R, Nguyenle K, Serrano E, Ondatje B, Benhaghnazar RL, Gray HB, Gross Z, Yu J, Svendsen CN, Abrol R, Medina-Kauwe LK. Systemic HER3 ligand-mimicking nanobioparticles enter the brain and reduce intracranial tumour growth. Nat Nanotechnol. 2025 Feb 21. doi: 10.1038/s41565-025-01867-7. Epub ahead of print. PMID: 39984637.

Tags: Cedars Sinai DoM, Infectious Diseases, Publications

Uptake, Geographic Access, and Outcomes of Transcatheter Mitral Valve Repair in the United States

Watanabe A, Ueyama HA, Miyamoto Y, Gotanda H, Kaneko T, Latib A, Kolte D, Baron SJ, Secemsky E, Laham RJ, Tsugawa Y, Kuno T. Uptake,[...]

Ferumoxytol-Enhanced Cardiovascular Magnetic Resonance Imaging: Applications and Technical Advances

Nguyen KL, Loke YH, Li JM, Bedayat A, Yang HJ, Xie Y, Christodoulou AG, Li D, Zhong X, Finn JP. Ferumoxytol-Enhanced Cardiovascular Magnetic Resonance Imaging:[...]

Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status

Bazhenova L, Hodgson JG, Camidge DR, Langer CJ, Huber RM, Kim DW, Reckamp KL, Ahn MJ, Tan DSW, Patel JD, Vincent S, Li C, Humphries[...]